Fundz

MelliCell awarded NIH/NIDDK SEED Grant to advance adipocyte therapies for chronic diseases in collaboration with Mass General Brigham.

PRIVATEOct 25, 2024

Round Type

Seed

NewtonBiotechnology

Description

MelliCell Inc. has secured a prestigious grant from the NIH/NIDDK SEED Fund to enhance innovation in adipocyte-based therapies, collaborating with Mass General Brigham. This funding will aid in their mission to harness fat cells for therapeutic advancements in diabetes and obesity.

Quick answer

MelliCell raised an undisclosed amount in a Seed round, dated October 25, 2024. MelliCell is based in Newton, Massachusetts, United States.

How much did MelliCell raise?
MelliCell raised an undisclosed amount in a Seed round on October 25, 2024.
What does MelliCell do?
MelliCell develops therapeutics for diabetes and obesity using proprietary technologies that model of weight gain in human fat cells in vitro.
Where is MelliCell based and how big is it?
MelliCell is based in Newton, Massachusetts, United States.
Who are the decision-makers at MelliCell?
Fundz holds 1 contact at MelliCell. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as MelliCell that raised within 45 days of this round, from Fundz verified event records.

  • Qi Biodesign raised $75M (Series A) on December 9, 2024.
  • Senti Biosciences raised $38M on December 9, 2024.
  • Abselion raised $8.4M (Series A) on December 9, 2024.
  • Citryll raised $89M (Series B) on December 9, 2024.
  • Canton Strategic Holdings, Inc. raised $2M (Seed) on December 9, 2024.
  • Mythic Therapeutics raised $30M on December 9, 2024.

Who to call at MelliCell, and when

A new round usually means MelliCell is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MelliCell raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MelliCell, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MelliCell. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MelliCell

Location

55 Chapel St.

Newton, Massachusetts, United States

About

MelliCell develops therapeutics for diabetes and obesity using proprietary technologies that model of weight gain in human fat cells in vitro. Our core technology enables discovery of therapeutic targets and leads, while reducing the time and money required for efficacy screening. It efficiently turns human stem cells into fat cells and accelerates their growth to sizes that are thousands of times larger than conventional limits and that match the sizes of mature fat cells in adults. Changes in fat cell size are how adults gain (or lose) weight, and increased fat cell size predicts diabetes better than obesity per se. The products we develop will treat obesity and diabetes by shrinking fat cell size and by preventing compromised metabolism in enlarged cells. We differentiate ourselves from existing therapies (e.g. GLP-1 analogs, SGLT2 inhibitors, anorexiants, intestinal lipase inhibitors, insulin secretagogues) by focusing on adipocyte-intrinsic mechanisms of action enabled by our core technology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MelliCell raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for MelliCell's next move

See what Strategic adds

MelliCell raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.